These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6701988)

  • 21. Reassessing the therapeutic range for theophylline: another perspective.
    Weinberger MM; Hendeles L
    Pharmacotherapy; 1993; 13(6):598-601. PubMed ID: 8302684
    [No Abstract]   [Full Text] [Related]  

  • 22. [Theophylline poisoning with particular attention to cardiac complications].
    Andersen E; Jakobsen S; Jørgensen C; Damgaard-Iversen B
    Ugeskr Laeger; 1984 Jun; 146(23):1719-20. PubMed ID: 6506255
    [No Abstract]   [Full Text] [Related]  

  • 23. [The usefulness of the bayesian method for the prediction of plasma theophylline levels in asthmatic children during RTC therapy by the sustained preparation of theophylline].
    Okabe T; Hida M; Maruyama K; Kohgo T; Shibuya M; Ohashi A
    Arerugi; 1994 Apr; 43(4):563-70. PubMed ID: 8031252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
    Kaik G
    Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interaction between ranitidine and theophylline].
    Pérez-Blanco FJ; Huertas González JM; Morata García de la Puerta IJ; Saucedo Sánchez R
    Rev Clin Esp; 1995 May; 195(5):359-60. PubMed ID: 7617950
    [No Abstract]   [Full Text] [Related]  

  • 26. [The pharmacokinetic characteristics of theophylline in patients with chronic nonspecific intestinal diseases in relation to its routes of administration into the gastrointestinal tract].
    Kukes VG; Fazylov AV; Kirkin BV; Kurapov AP; Blinov IL
    Ter Arkh; 1993; 65(2):52-4. PubMed ID: 9133013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study on the clinical efficacy of theophylline variable serum concentrations therapy and round-the-clock therapy.
    Nakahara Y; Murata M; Suzuki T; Ohtsu F; Nagasawa K
    Int J Clin Pharmacol Res; 1998; 18(1):1-11. PubMed ID: 9604729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of drug interactions on outcomes of patients receiving warfarin or theophylline.
    Jankel CA; McMillan JA; Martin BC
    Am J Hosp Pharm; 1994 Mar; 51(5):661-6. PubMed ID: 8203385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma theophylline assay service for outpatients.
    Paterson JW; Yellin RH; Ilett KF; Madsen BW
    Ther Drug Monit; 1981; 3(1):51-5. PubMed ID: 7233489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidelines for avoiding theophylline overdose.
    Hendeles L; Weinberger M
    N Engl J Med; 1979 May; 300(21):1217. PubMed ID: 431654
    [No Abstract]   [Full Text] [Related]  

  • 31. [Individualization of the dosage of oral theophylline with regular increase method and serum level control in 55 asthmatic children (author's transl)].
    Cabanas R; Peña J; Tojo R; Fuster M; Vázquez MC; Cortizo E; Castro-Gago M
    An Esp Pediatr; 1981 Feb; 14(2):89-96. PubMed ID: 7258855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unusual cause of theophylline toxicity.
    Gotz VP; Drayer DE; Schned ES; Reidenberg MM
    N Y State J Med; 1979 Jul; 79(8):1232-4. PubMed ID: 287921
    [No Abstract]   [Full Text] [Related]  

  • 33. Theophylline toxicity following coadministration of viloxazine.
    Thomson AH; Addis GJ; McGovern EM; McDonald NJ
    Ther Drug Monit; 1988; 10(3):359-60. PubMed ID: 3176117
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline].
    Gregori P; Hader S; Samiri H; Wiemann M; Yousif MJ; Kiebart M
    Fortschr Med; 1997 Jan; 115(1-2):54-5. PubMed ID: 9102383
    [No Abstract]   [Full Text] [Related]  

  • 35. [The pharmacodynamics of theophylline (euphylline)].
    Tsoĭ AN; Bogovskiĭ BP; Saprygina TV; Kniazev RM; Titova EV; Kukes VG
    Ter Arkh; 1993; 65(8):36-40. PubMed ID: 8211799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical review of patients with seizures that developed during theophylline administration--(III) Safety of theophylline examined in patients who had sequelae or died].
    Odajima Y; Nakano H; Kato T; Okada K
    Arerugi; 2008 May; 57(5):536-42. PubMed ID: 18520175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
    Arens PJ
    Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obstructive airway disease: rational therapy with theophylline agents.
    Matthay RA; Depew CC
    Geriatrics; 1980 Feb; 35(2):65-77. PubMed ID: 7356590
    [No Abstract]   [Full Text] [Related]  

  • 40. [Successful combination therapy in bronchial asthma. Anti-obstructive and anti-inflammatory treatment].
    Thomsen M; Zahn T
    Fortschr Med; 1994 Jan; 112(1-2):39-42. PubMed ID: 8144119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.